- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Value of Adherence
Darius Lakdawalla, PhD, addresses the value of diabetes patients' adherence in this clip.
Darius Lakdawalla, PhD, addresses the value of diabetes patients’ adherence in this clip. According to Dr Lakdawalla, diabetes patients account for about one-third of total Medicare spending. By 2050, that percentage could be one half of Medicare spending. Risk factors, including the rise of obesity in the population, are contributing to the increase of diabetes diagnoses.
To control rising costs, Dr Lakdawalla suggests interventions must be made, including biomedical innovation and technologies that can improve medication adherence. Improved adherence could be worth almost $13,000 per patient with diabetes
.
“Some payers have been reluctant to reimburse technologies that focus specifically on adherence and convenience and those kinds of outcomes,” says Dr Lakdawalla. “That's changing with the implementation of the ACA and other kinds of policies in which payers are taking a more holistic role in care. Those changes, I think, are to be encouraged.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
